Mongolian Part of the Transboundary Sailugem Natural Plague Focus in 2017. Communication 1. Epizootic condition

Objective – estimation of current epizootic condition of Mongolian part of transboundary Sailugem natural plague focus. Materials and methods. Epizootiological survey was performed for the area of 2335 km2, 277 mammals and 516 ectoparasites were investigated for plague. Results and conclusions. Eight Yersinia pestis subsp. pestis strains were isolated, including 7 strains – from grey marmots (6 – from the remains of meals of predatory birds, 1 from a corpse) and 1 – from long-tailed souslik (corpse). Y. pestis DNA was detected in 52 objects. Serological samples showed 40 positive results. Epizootic manifestations, confirmed by isolation of Y. pestis cultures, detection of plague microbe DNA, and positive serological results, were observed across the area of 1611 km2 covering 69 % of the inspected territory. Epizootic results indicated high infection rate of mass mammal species and first of all grey marmots. The data demonstrated that the extended plague epizooty caused by Y. pestis of the main subspecies occurred in the inspected territory in the carrier settlements. For the first time the circulation of Y. pestis subsp. pestis was registered in the Mongolian part of the transboundary Sailugem focus

Biologically Active Substances in Buckwheat ( Fagopyrum tataricum L.) Cul- tivated in Mongolia

From thoroughly air-dried samples of buckwheat plant, we revealed a biochemical composition of 14 components. By thin layer chromatography and quantitative analysis methods we showed that buck- wheat has 7 kinds of alkaloids with one dominating alkaloid, and the total weight of all alkaloids equals 0.05%. We also determined the aboveground parts of buckwheat contain the following substances: rutin- 3.14%, fat-0.91%, protein-8.23%, carbohydrate-18.52%, monosaccharide-0.37%, disaccharides-1.11%, vitamin C-0.02%, ash-10.57%, acidity-0.05, carotine-15.6mg, cellulose-40.8%, tannin-1.70%, soluble pectins-0.266%, insoluble pectins-0.507%, total amount of alkaloids-0.05%

Public Awareness and Practices Towards Self-Medication with Antibiotics Among Malaysian Population: Questionnaire Development and Pilot Testing

Not Availabl

International Nosocomial Infection Control Consortium report, data summary of 50 countries for 2010-2015: Device-associated module

•We report INICC device-associated module data of 50 countries from 2010-2015.•We collected prospective data from 861,284 patients in 703 ICUs for 3,506,562 days.•DA-HAI rates and bacterial resistance were higher in the INICC ICUs than in CDC-NHSN's.•Device utilization ratio in the INICC ICUs was similar to CDC-NHSN's. Background: We report the results of International Nosocomial Infection Control Consortium (INICC) surveillance study from January 2010-December 2015 in 703 intensive care units (ICUs) in Latin America, Europe, Eastern Mediterranean, Southeast Asia, and Western Pacific. Methods: During the 6-year study period, using Centers for Disease Control and Prevention National Healthcare Safety Network (CDC-NHSN) definitions for device-associated health care-associated infection (DA-HAI), we collected prospective data from 861,284 patients hospitalized in INICC hospital ICUs for an aggregate of 3,506,562 days. Results: Although device use in INICC ICUs was similar to that reported from CDC-NHSN ICUs, DA-HAI rates were higher in the INICC ICUs: in the INICC medical-surgical ICUs, the pooled rate of central line-associated bloodstream infection, 4.1 per 1,000 central line-days, was nearly 5-fold higher than the 0.8 per 1,000 central line-days reported from comparable US ICUs, the overall rate of ventilator-associated pneumonia was also higher, 13.1 versus 0.9 per 1,000 ventilator-days, as was the rate of catheter-associated urinary tract infection, 5.07 versus 1.7 per 1,000 catheter-days. From blood cultures samples, frequencies of resistance of Pseudomonas isolates to amikacin (29.87% vs 10%) and to imipenem (44.3% vs 26.1%), and of Klebsiella pneumoniae isolates to ceftazidime (73.2% vs 28.8%) and to imipenem (43.27% vs 12.8%) were also higher in the INICC ICUs compared with CDC-NHSN ICUs. Conclusions: Although DA-HAIs in INICC ICU patients continue to be higher than the rates reported in CDC-NSHN ICUs representing the developed world, we have observed a significant trend toward the reduction of DA-HAI rates in INICC ICUs as shown in each international report. It is INICC's main goal to continue facilitating education, training, and basic and cost-effective tools and resources, such as standardized forms and an online platform, to tackle this problem effectively and systematically